ZNF570
gene geneOn this page
Also known as FLJ30791
Summary
ZNF570 (zinc finger protein 570, HGNC:26416) is a protein-coding gene on chromosome 19q13.12, encoding Zinc finger protein 570 (Q96NI8). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 148268 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 65 total
- MANE Select transcript:
NM_144694
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26416 |
| Approved symbol | ZNF570 |
| Name | zinc finger protein 570 |
| Location | 19q13.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ30791 |
| Ensembl gene | ENSG00000171827 |
| Ensembl biotype | protein_coding |
| Entrez | 148268 |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 6 protein_coding, 3 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000330173, ENST00000586475, ENST00000587363, ENST00000588644, ENST00000589725, ENST00000590664, ENST00000591380, ENST00000867039, ENST00000927574, ENST00000943174
RefSeq mRNA: 6 — MANE Select: NM_144694
NM_001300993, NM_001321991, NM_001321992, NM_001321993, NM_001321994, NM_144694
CCDS: CCDS12504, CCDS74355
Canonical transcript exons
ENST00000330173 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000951756 | 37483879 | 37488652 |
| ENSE00002250533 | 37469356 | 37469557 |
| ENSE00002463461 | 37476339 | 37476434 |
| ENSE00003555498 | 37475881 | 37476007 |
| ENSE00003626242 | 37470304 | 37470387 |
Expression profiles
Bgee: expression breadth ubiquitous, 238 present calls, max score 88.68.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 4.0820 / max 108.3331, expressed in 1421 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 175555 | 2.7809 | 1238 |
| 175554 | 0.7429 | 464 |
| 175556 | 0.4229 | 211 |
| 175557 | 0.1354 | 53 |
Top tissues by expression
247 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 88.68 | gold quality |
| calcaneal tendon | UBERON:0003701 | 84.55 | gold quality |
| cortical plate | UBERON:0005343 | 82.40 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 81.66 | gold quality |
| medial globus pallidus | UBERON:0002477 | 81.54 | gold quality |
| secondary oocyte | CL:0000655 | 79.94 | silver quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.63 | gold quality |
| ganglionic eminence | UBERON:0004023 | 79.45 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 78.96 | silver quality |
| islet of Langerhans | UBERON:0000006 | 78.80 | gold quality |
| colonic epithelium | UBERON:0000397 | 78.54 | gold quality |
| globus pallidus | UBERON:0001875 | 78.44 | gold quality |
| parietal pleura | UBERON:0002400 | 77.45 | gold quality |
| tendon | UBERON:0000043 | 77.39 | gold quality |
| corpus callosum | UBERON:0002336 | 76.83 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 76.67 | silver quality |
| cerebellar vermis | UBERON:0004720 | 76.07 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 75.80 | gold quality |
| stromal cell of endometrium | CL:0002255 | 75.54 | gold quality |
| testis | UBERON:0000473 | 75.30 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 75.27 | gold quality |
| ventricular zone | UBERON:0003053 | 75.12 | gold quality |
| oocyte | CL:0000023 | 75.11 | silver quality |
| right testis | UBERON:0004534 | 75.01 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 74.84 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 74.81 | silver quality |
| left testis | UBERON:0004533 | 74.64 | gold quality |
| oviduct epithelium | UBERON:0004804 | 74.62 | gold quality |
| primary visual cortex | UBERON:0002436 | 74.43 | gold quality |
| tibia | UBERON:0000979 | 74.42 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 4.92 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
117 targeting ZNF570, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-33A-5P | 99.99 | 68.62 | 1055 |
| HSA-MIR-33B-5P | 99.99 | 68.58 | 1062 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-LET-7F-2-3P | 99.98 | 70.98 | 2588 |
| HSA-MIR-1185-1-3P | 99.98 | 71.04 | 2593 |
| HSA-MIR-1185-2-3P | 99.98 | 71.04 | 2593 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-507 | 99.97 | 70.11 | 1915 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-557 | 99.96 | 70.01 | 1640 |
| HSA-MIR-9983-3P | 99.94 | 71.48 | 3631 |
| HSA-MIR-144-3P | 99.94 | 73.98 | 2698 |
| HSA-MIR-101-3P | 99.94 | 75.03 | 2230 |
| HSA-MIR-552-5P | 99.93 | 68.56 | 1583 |
| HSA-MIR-450B-5P | 99.92 | 71.48 | 3175 |
| HSA-MIR-5680 | 99.91 | 69.83 | 3421 |
| HSA-MIR-3529-3P | 99.90 | 73.55 | 3045 |
| HSA-MIR-627-3P | 99.90 | 71.42 | 3316 |
| HSA-MIR-4731-5P | 99.89 | 67.23 | 2537 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp39 | ENSMUSG00000037001 |
| rattus_norvegicus | Zfp39 | ENSRNOG00000014712 |
Paralogs (38): ZFX (ENSG00000005889), ZBTB11 (ENSG00000066422), ZFAT (ENSG00000066827), ZFY (ENSG00000067646), ZNF586 (ENSG00000083828), IKZF5 (ENSG00000095574), ZNF419 (ENSG00000105136), ZNF549 (ENSG00000121406), ZSCAN20 (ENSG00000121903), ZNF304 (ENSG00000131845), PRDM15 (ENSG00000141956), ZNF660 (ENSG00000144792), ZNF711 (ENSG00000147180), ZNF773 (ENSG00000152439), ZNF256 (ENSG00000152454), ZNF837 (ENSG00000152475), ZNF691 (ENSG00000164011), ZNF610 (ENSG00000167554), E4F1 (ENSG00000167967), ZNF562 (ENSG00000171466), ZNF561 (ENSG00000171469), ZNF584 (ENSG00000171574), ZIK1 (ENSG00000171649), ZSCAN2 (ENSG00000176371), ZNF552 (ENSG00000178935), ZNF154 (ENSG00000179909), ZNF792 (ENSG00000180884), ZNF793 (ENSG00000188227), ZNF548 (ENSG00000188785), ZNF79 (ENSG00000196152), ZNF418 (ENSG00000196724), ZNF772 (ENSG00000197128), ZNF583 (ENSG00000198440), ZNF480 (ENSG00000198464), ZNF551 (ENSG00000204519), ZNF134 (ENSG00000213762), ZNF587B (ENSG00000269343), ZNF8 (ENSG00000278129)
Protein
Protein identifiers
Zinc finger protein 570 — Q96NI8 (reviewed: Q96NI8)
All UniProt accessions (6): Q96NI8, K7EMF5, K7ENX9, K7EP39, K7EP64, K7EQY8
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q96NI8-1 | 1 | yes |
| Q96NI8-2 | 2 |
RefSeq proteins (6): NP_001287922, NP_001308920, NP_001308921, NP_001308922, NP_001308923, NP_653295* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352
UniProt features (14 total): zinc finger region 11, chain 1, domain 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96NI8-F1 | 71.36 | 0.49 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 74 (showing top):
MAF_Q6, STAT1_02, YKACATTT_UNKNOWN, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, STAT1_03, SNACANNNYSYAGA_UNKNOWN, ALX4_01, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, ALKBH3_TARGET_GENES, ARID5B_TARGET_GENES, CBX5_TARGET_GENES, CBX7_TARGET_GENES, GLI4_TARGET_GENES, H1_6_TARGET_GENES, KLF7_TARGET_GENES
GO Biological Process (3): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355), positive regulation of transcription by RNA polymerase II (GO:0045944)
GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), transcription cis-regulatory region binding (GO:0000976), DNA binding (GO:0003677), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transcription by RNA polymerase II | 2 |
| regulation of transcription by RNA polymerase II | 2 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| positive regulation of DNA-templated transcription | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| transition metal ion binding | 1 |
| transcription regulatory region nucleic acid binding | 1 |
| sequence-specific double-stranded DNA binding | 1 |
| nucleic acid binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
396 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF570 | LINC02914 | Q52M58 | 519 |
| ZNF570 | FOXL2NB | Q6ZUU3 | 507 |
| ZNF570 | AJAP1 | Q9UKB5 | 506 |
| ZNF570 | ANKRD65 | E5RJM6 | 480 |
| ZNF570 | C3orf62 | Q6ZUJ4 | 447 |
| ZNF570 | MT1A | P04731 | 445 |
| ZNF570 | NUDCD2 | Q8WVJ2 | 427 |
| ZNF570 | HOXC4 | P09017 | 420 |
| ZNF570 | TMEM60 | Q9H2L4 | 380 |
| ZNF570 | LCN9 | Q8WX39 | 370 |
| ZNF570 | HOXB4 | P17483 | 370 |
| ZNF570 | SHANK2 | Q9UPX8 | 370 |
| ZNF570 | RFPL1 | O75677 | 357 |
| ZNF570 | MRPL54 | Q6P161 | 348 |
| ZNF570 | KCNJ18 | B7U540 | 325 |
IntAct
0 interactions, top by confidence:
BioGRID (2): ZNF570 (Proximity Label-MS), ZNF570 (Proximity Label-MS)
ESM2 similar proteins: A0JNB1, A6QLU5, O75123, O75820, P10076, P10755, P16374, P17031, P17097, P17141, P51814, Q02975, Q08ER8, Q14588, Q14590, Q32KN0, Q3V080, Q4V8A8, Q5CZA5, Q5R4K8, Q5R5Q6, Q5R9S5, Q5RBX0, Q61751, Q6GQR8, Q6P560, Q6ZMS4, Q7TSH9, Q7TSI0, Q7Z3I7, Q7Z3V5, Q8BLB0, Q8N141, Q8N184, Q8N823, Q8N8J6, Q8N9F8, Q8TBZ5, Q8TF47, Q96ND8
Diamond homologs: A0A1W2PQL4, A6NK75, A6NN14, A6NNF4, A6NP11, A8MQ14, A8MTY0, A8MUV8, A8MXY4, B4DX44, B4DXR9, E9PYI1, O14628, O43345, O75290, O75346, O75373, O75437, O95780, P0CB33, P0DKX0, P0DPD5, P16373, P17019, P17038, P21506, P35789, P52736, P52738, P52744, Q03923, Q03924, Q03936, Q03938, Q05481, Q14586, Q14593, Q14929, Q15928, Q3KNS6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
65 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 59 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1079 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:37469277:GAC:G | donor_gain | 1.0000 |
| 19:37469303:G:GT | donor_gain | 1.0000 |
| 19:37476006:GG:G | donor_gain | 1.0000 |
| 19:37476007:GG:G | donor_gain | 1.0000 |
| 19:37476008:G:C | donor_loss | 1.0000 |
| 19:37476008:G:GG | donor_gain | 1.0000 |
| 19:37476009:T:A | donor_loss | 1.0000 |
| 19:37476335:GCA:G | acceptor_loss | 1.0000 |
| 19:37476336:CAG:C | acceptor_loss | 1.0000 |
| 19:37476337:A:AG | acceptor_gain | 1.0000 |
| 19:37476337:AGG:A | acceptor_loss | 1.0000 |
| 19:37476338:G:GG | acceptor_gain | 1.0000 |
| 19:37469158:G:GT | donor_gain | 0.9900 |
| 19:37469367:GGCCC:G | donor_gain | 0.9900 |
| 19:37469368:GCCCG:G | donor_gain | 0.9900 |
| 19:37469652:GGCT:G | donor_gain | 0.9900 |
| 19:37469653:GCTG:G | donor_gain | 0.9900 |
| 19:37470302:A:AG | acceptor_gain | 0.9900 |
| 19:37470303:G:GG | acceptor_gain | 0.9900 |
| 19:37475875:TTTCA:T | acceptor_loss | 0.9900 |
| 19:37475876:TTCAG:T | acceptor_loss | 0.9900 |
| 19:37475877:TCA:T | acceptor_loss | 0.9900 |
| 19:37475879:A:G | acceptor_loss | 0.9900 |
| 19:37475880:G:GA | acceptor_loss | 0.9900 |
| 19:37475880:GGA:G | acceptor_gain | 0.9900 |
| 19:37475963:AC:A | donor_gain | 0.9900 |
| 19:37475965:A:AG | donor_gain | 0.9900 |
| 19:37475966:G:GG | donor_gain | 0.9900 |
| 19:37475991:GATC:G | donor_gain | 0.9900 |
| 19:37476004:CTGG:C | donor_gain | 0.9900 |
AlphaMissense
3572 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:37484469:T:C | F283L | 0.998 |
| 19:37484471:C:A | F283L | 0.998 |
| 19:37484471:C:G | F283L | 0.998 |
| 19:37484805:T:C | F395L | 0.998 |
| 19:37484807:T:A | F395L | 0.998 |
| 19:37484807:T:G | F395L | 0.998 |
| 19:37484889:T:C | F423L | 0.998 |
| 19:37484891:C:A | F423L | 0.998 |
| 19:37484891:C:G | F423L | 0.998 |
| 19:37484973:T:C | F451L | 0.998 |
| 19:37484975:T:A | F451L | 0.998 |
| 19:37484975:T:G | F451L | 0.998 |
| 19:37485057:T:C | F479L | 0.998 |
| 19:37485059:T:A | F479L | 0.998 |
| 19:37485059:T:G | F479L | 0.998 |
| 19:37484385:T:C | F255L | 0.997 |
| 19:37484387:C:A | F255L | 0.997 |
| 19:37484387:C:G | F255L | 0.997 |
| 19:37484553:T:C | F311L | 0.997 |
| 19:37484555:C:A | F311L | 0.997 |
| 19:37484555:C:G | F311L | 0.997 |
| 19:37484637:T:C | F339L | 0.997 |
| 19:37484639:T:A | F339L | 0.997 |
| 19:37484639:T:G | F339L | 0.997 |
| 19:37484721:T:C | F367L | 0.997 |
| 19:37484723:T:A | F367L | 0.997 |
| 19:37484723:T:G | F367L | 0.997 |
| 19:37484916:C:G | H432D | 0.994 |
| 19:37484918:T:A | H432Q | 0.994 |
| 19:37484918:T:G | H432Q | 0.994 |
dbSNP variants (sampled 300 via entrez): RS1000164546 (19:37484128 G>T), RS1000538705 (19:37488488 A>G), RS1000687284 (19:37481676 A>T), RS1001123030 (19:37485926 C>T), RS1001226512 (19:37486472 T>A), RS1001237194 (19:37485672 C>A,G), RS1001365935 (19:37475796 A>G), RS1001566157 (19:37478488 T>C,G), RS1001590538 (19:37482748 C>T), RS1001766804 (19:37466740 T>C), RS1001832937 (19:37468922 G>A), RS1001935843 (19:37472194 G>A), RS1001978196 (19:37487834 G>A), RS1001988769 (19:37472537 T>G), RS1002128615 (19:37487600 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
21 total (human), top 21 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, increases expression | 2 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| terbufos | increases methylation | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| jinfukang | decreases expression, affects cotreatment | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Cisplatin | affects cotreatment, decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Fonofos | increases methylation | 1 |
| Parathion | increases methylation | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Urethane | increases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Antirheumatic Agents | increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_F1RK | HyCyte MCF-7 KO-hZNF570 | Cancer cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.